Skip to main content
Top
Published in: Journal of Neuroinflammation 1/2011

Open Access 01-12-2011 | Review

Neurovascular dysfunction, inflammation and endothelial activation: Implications for the pathogenesis of Alzheimer's disease

Author: Paula Grammas

Published in: Journal of Neuroinflammation | Issue 1/2011

Login to get access

Abstract

Alzheimer's disease (AD) is an age-related disorder characterized by progressive cognitive decline and dementia. Alzheimer's disease is an increasingly prevalent disease with 5.3 million people in the United States currently affected. This number is a 10 percent increase from previous estimates and is projected to sharply increase to 8 million by 2030; it is the sixth-leading cause of death. In the United States the direct and indirect costs of Alzheimer's and other dementias to Medicare, Medicaid and businesses amount to more than $172 billion each year. Despite intense research efforts, effective disease-modifying therapies for this devastating disease remain elusive. At present, the few agents that are FDA-approved for the treatment of AD have demonstrated only modest effects in modifying clinical symptoms for relatively short periods and none has shown a clear effect on disease progression. New therapeutic approaches are desperately needed. Although the idea that vascular defects are present in AD and may be important in disease pathogenesis was suggested over 25 years ago, little work has focused on an active role for cerebrovascular mechanisms in the pathogenesis of AD. Nevertheless, increasing literature supports a vascular-neuronal axis in AD as shared risk factors for both AD and atherosclerotic cardiovascular disease implicate vascular mechanisms in the development and/or progression of AD. Also, chronic inflammation is closely associated with cardiovascular disease, as well as a broad spectrum of neurodegenerative diseases of aging including AD. In this review we summarize data regarding, cardiovascular risk factors and vascular abnormalities, neuro- and vascular-inflammation, and brain endothelial dysfunction in AD. We conclude that the endothelial interface, a highly synthetic bioreactor that produces a large number of soluble factors, is functionally altered in AD and contributes to a noxious CNS milieu by releasing inflammatory and neurotoxic species.
Appendix
Available only for authorised users
Literature
2.
go back to reference Formichi P, Parnetti L, Radi E, Cevenini G, Dotti MT, Federico A: CSF biomarkers profile in CADASIL-A model of pure vascular dementia: Usefulness in differential diagnosis in the dementia disorder. Int J Alzheimers Dis. 2010, 2010: 959257 Formichi P, Parnetti L, Radi E, Cevenini G, Dotti MT, Federico A: CSF biomarkers profile in CADASIL-A model of pure vascular dementia: Usefulness in differential diagnosis in the dementia disorder. Int J Alzheimers Dis. 2010, 2010: 959257
3.
go back to reference Sparks DL, Hunsaker JC, Scheff SW, Kryscio RJ, Henson JL, Markesbery WR: Cortical senile plaques in coronary artery disease, aging and Alzheimer's disease. Neurobiol Aging. 1990, 11: 601-607. 10.1016/0197-4580(90)90024-T.PubMed Sparks DL, Hunsaker JC, Scheff SW, Kryscio RJ, Henson JL, Markesbery WR: Cortical senile plaques in coronary artery disease, aging and Alzheimer's disease. Neurobiol Aging. 1990, 11: 601-607. 10.1016/0197-4580(90)90024-T.PubMed
4.
go back to reference Sparks DL, Liu J, Scheff SW, Coyne CM, Hunsker JC: Temporal sequence of plaque formation in the cerebral cortex of non-demented individuals. J Neuropathol Exp Neurol. 1993, 52: 135-142. 10.1097/00005072-199303000-00006.PubMed Sparks DL, Liu J, Scheff SW, Coyne CM, Hunsker JC: Temporal sequence of plaque formation in the cerebral cortex of non-demented individuals. J Neuropathol Exp Neurol. 1993, 52: 135-142. 10.1097/00005072-199303000-00006.PubMed
5.
go back to reference Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance M, Enghild J, Salvesen GS, Roses AD: Apolipoprotein E: High-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci USA. 1993, 90: 1977-1981. 10.1073/pnas.90.5.1977.PubMedCentralPubMed Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance M, Enghild J, Salvesen GS, Roses AD: Apolipoprotein E: High-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci USA. 1993, 90: 1977-1981. 10.1073/pnas.90.5.1977.PubMedCentralPubMed
6.
go back to reference Hofman A, Ott A, Breteler MM, Bots ML, Slooter AJ, van Harskamp F, van Duijn CN, Van Broeckhoven C, Grobbee DE: Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study. Lancet. 1997, 349: 151-154. 10.1016/S0140-6736(96)09328-2.PubMed Hofman A, Ott A, Breteler MM, Bots ML, Slooter AJ, van Harskamp F, van Duijn CN, Van Broeckhoven C, Grobbee DE: Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study. Lancet. 1997, 349: 151-154. 10.1016/S0140-6736(96)09328-2.PubMed
7.
go back to reference Miller JW: Homocysteine and Alzheimer's disease. Nutr Rev. 1999, 57: 126-129.PubMed Miller JW: Homocysteine and Alzheimer's disease. Nutr Rev. 1999, 57: 126-129.PubMed
8.
go back to reference Stewart R, Prince M, Mann A: Vascular risk factors and Alzheimer's disease. Aust N Z J Psychiatry. 1999, 33: 809-813. 10.1046/j.1440-1614.1999.00657.x.PubMed Stewart R, Prince M, Mann A: Vascular risk factors and Alzheimer's disease. Aust N Z J Psychiatry. 1999, 33: 809-813. 10.1046/j.1440-1614.1999.00657.x.PubMed
9.
go back to reference Schmidt R, Schmidt H, Fazekas F: Vascular risk factors in dementia. J Neurol. 2000, 247: 81-87. 10.1007/s004150050021.PubMed Schmidt R, Schmidt H, Fazekas F: Vascular risk factors in dementia. J Neurol. 2000, 247: 81-87. 10.1007/s004150050021.PubMed
10.
go back to reference Shi J, Perry G, Smith MA, Friedland RP: Vascular abnormalities: the insidious pathogenesis of Alzheimer's disease. Neurobiol Aging. 2000, 21: 357-361. 10.1016/S0197-4580(00)00119-6.PubMed Shi J, Perry G, Smith MA, Friedland RP: Vascular abnormalities: the insidious pathogenesis of Alzheimer's disease. Neurobiol Aging. 2000, 21: 357-361. 10.1016/S0197-4580(00)00119-6.PubMed
11.
go back to reference Sparks DL, Martin TA, Gross DR, Hunsaker JC: Link between heart disease, cholesterol, and Alzheimer's disease: a review. Microsc Res Tech. 2000, 50: 287-290. 10.1002/1097-0029(20000815)50:4<287::AID-JEMT7>3.0.CO;2-L.PubMed Sparks DL, Martin TA, Gross DR, Hunsaker JC: Link between heart disease, cholesterol, and Alzheimer's disease: a review. Microsc Res Tech. 2000, 50: 287-290. 10.1002/1097-0029(20000815)50:4<287::AID-JEMT7>3.0.CO;2-L.PubMed
12.
go back to reference Marx J: Alzheimer's disease. Bad for the heart, bad for the mind?. Science. 2001, 294: 508-509. 10.1126/science.294.5542.508.PubMed Marx J: Alzheimer's disease. Bad for the heart, bad for the mind?. Science. 2001, 294: 508-509. 10.1126/science.294.5542.508.PubMed
13.
go back to reference Rhodin JA, Thomas T: A vascular connection to Alzheimer's disease. Microcirculation. 2001, 8: 207-220.PubMed Rhodin JA, Thomas T: A vascular connection to Alzheimer's disease. Microcirculation. 2001, 8: 207-220.PubMed
14.
go back to reference de la Torre JC: Alzheimer disease as a vascular disorder: nosological evidence. Stroke. 2002, 3: 1152-1162. 10.1161/01.STR.0000014421.15948.67. de la Torre JC: Alzheimer disease as a vascular disorder: nosological evidence. Stroke. 2002, 3: 1152-1162. 10.1161/01.STR.0000014421.15948.67.
15.
go back to reference Pansari K, Gupta A, Thomas P: Alzheimer's disease and vascular factors: facts and theories. Int J Clin Pract. 2002, 56: 197-203.PubMed Pansari K, Gupta A, Thomas P: Alzheimer's disease and vascular factors: facts and theories. Int J Clin Pract. 2002, 56: 197-203.PubMed
16.
go back to reference Seshadri S, Beiser A, Selhub J, Jacques PF, Rosenberg IH, D'Agostino RB, Wilson PW, Wolff PA: Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med. 2002, 346: 476-483. 10.1056/NEJMoa011613.PubMed Seshadri S, Beiser A, Selhub J, Jacques PF, Rosenberg IH, D'Agostino RB, Wilson PW, Wolff PA: Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med. 2002, 346: 476-483. 10.1056/NEJMoa011613.PubMed
17.
go back to reference Iadecola C: Neurovascular regulation in the normal brain and in Alzheimer's disease. Nat Rev Neurosci. 2004, 5: 347-360. 10.1038/nrn1387.PubMed Iadecola C: Neurovascular regulation in the normal brain and in Alzheimer's disease. Nat Rev Neurosci. 2004, 5: 347-360. 10.1038/nrn1387.PubMed
18.
go back to reference Ruitenberg A, den Heijer T, Bakker SL, van Swieten JC, Koudstaal PJ, Hofman A, Breteler MM: Cerebral hypoperfusion and clinical onset of dementia: the Rotterdam Study. Ann Neurol. 2005, 57: 789-794. 10.1002/ana.20493.PubMed Ruitenberg A, den Heijer T, Bakker SL, van Swieten JC, Koudstaal PJ, Hofman A, Breteler MM: Cerebral hypoperfusion and clinical onset of dementia: the Rotterdam Study. Ann Neurol. 2005, 57: 789-794. 10.1002/ana.20493.PubMed
19.
go back to reference Zlokovic BV: Neurovascular mechanisms of Alzheimer's neurodegeneration. Trends Neurosci. 2005, 28: 202-208. 10.1016/j.tins.2005.02.001.PubMed Zlokovic BV: Neurovascular mechanisms of Alzheimer's neurodegeneration. Trends Neurosci. 2005, 28: 202-208. 10.1016/j.tins.2005.02.001.PubMed
20.
go back to reference de la Torre JC: How do heart disease and stroke become risk factors for Alzheimer's disease?. Neurol Res. 2006, 28: 637-644. 10.1179/016164106X130362.PubMed de la Torre JC: How do heart disease and stroke become risk factors for Alzheimer's disease?. Neurol Res. 2006, 28: 637-644. 10.1179/016164106X130362.PubMed
21.
go back to reference Stampfer MJ: Cardiovascular disease and Alzheimer's disease: common links. J Intern Med. 2006, 260: 211-223. 10.1111/j.1365-2796.2006.01687.x.PubMed Stampfer MJ: Cardiovascular disease and Alzheimer's disease: common links. J Intern Med. 2006, 260: 211-223. 10.1111/j.1365-2796.2006.01687.x.PubMed
22.
go back to reference Beach TG, Wilson JR, Sue LI, Newell A, Poston M, Cisneros R, Pandya Y, Esh C, Connor DJ, Sabbagh M, Walker DG, Roher AE: Circle of Willis atherosclerosis: association with Alzheimer's disease, neuritic plaques and neurofibrillary tangles. Acta Neuropathol. 2007, 113: 1-21. Beach TG, Wilson JR, Sue LI, Newell A, Poston M, Cisneros R, Pandya Y, Esh C, Connor DJ, Sabbagh M, Walker DG, Roher AE: Circle of Willis atherosclerosis: association with Alzheimer's disease, neuritic plaques and neurofibrillary tangles. Acta Neuropathol. 2007, 113: 1-21.
23.
go back to reference Lanari A, Silvestrelli G, De Dominicis P, Tomassoni D, Amenta F, Parnetti L: Arterial hypertension and cognitive dysfunction in physiologic and pathologic aging of the brain. Am J Geriatr Cardiol. 2007, 16: 158-164. 10.1111/j.1076-7460.2007.06502.x.PubMed Lanari A, Silvestrelli G, De Dominicis P, Tomassoni D, Amenta F, Parnetti L: Arterial hypertension and cognitive dysfunction in physiologic and pathologic aging of the brain. Am J Geriatr Cardiol. 2007, 16: 158-164. 10.1111/j.1076-7460.2007.06502.x.PubMed
24.
go back to reference Luchsinger JA, Reitz C, Patel B, Tang MX, Manly JJ, Mayeux R: Relation of diabetes to mild cognitive impairment. Arch Neurol. 2007, 64: 570-575. 10.1001/archneur.64.4.570.PubMed Luchsinger JA, Reitz C, Patel B, Tang MX, Manly JJ, Mayeux R: Relation of diabetes to mild cognitive impairment. Arch Neurol. 2007, 64: 570-575. 10.1001/archneur.64.4.570.PubMed
25.
go back to reference Van Oijen M, de Jong FJ, Witteman JC, Hofman A, Koudstaal PJ, Breteler MM: Atherosclerosis and risk for dementia. Ann Neurol. 2007, 61: 403-410. 10.1002/ana.21073.PubMed Van Oijen M, de Jong FJ, Witteman JC, Hofman A, Koudstaal PJ, Breteler MM: Atherosclerosis and risk for dementia. Ann Neurol. 2007, 61: 403-410. 10.1002/ana.21073.PubMed
26.
go back to reference Helzner EP, Luchsinger JA, Scarmeas N, Cosentino S, Brickman AM, Glymour MM, Stern Y: Contribution of vascular risk factors to the progression in Alzheimer's disease. Arch Neurol. 2009, 66: 343-348. 10.1001/archneur.66.3.343.PubMedCentralPubMed Helzner EP, Luchsinger JA, Scarmeas N, Cosentino S, Brickman AM, Glymour MM, Stern Y: Contribution of vascular risk factors to the progression in Alzheimer's disease. Arch Neurol. 2009, 66: 343-348. 10.1001/archneur.66.3.343.PubMedCentralPubMed
27.
go back to reference Altman R, Rutledge JC: The vascular contribution to Alzheimer's disease. Clin Sci (Lond). 2010, 119: 407-421. 10.1042/CS20100094. Altman R, Rutledge JC: The vascular contribution to Alzheimer's disease. Clin Sci (Lond). 2010, 119: 407-421. 10.1042/CS20100094.
28.
go back to reference de la Torre JC: The vascular hypothesis of Alzheimer's disease: bench to bedside and beyond. Neurodegener Dis. 2010, 7: 116-121. 10.1159/000285520.PubMed de la Torre JC: The vascular hypothesis of Alzheimer's disease: bench to bedside and beyond. Neurodegener Dis. 2010, 7: 116-121. 10.1159/000285520.PubMed
29.
go back to reference Iadecola C: The overlap between neurodegenerative and vascular factors in the pathogenesis of dementia. Acta Neuropathol. 2010, 120: 287-296. 10.1007/s00401-010-0718-6.PubMedCentralPubMed Iadecola C: The overlap between neurodegenerative and vascular factors in the pathogenesis of dementia. Acta Neuropathol. 2010, 120: 287-296. 10.1007/s00401-010-0718-6.PubMedCentralPubMed
30.
go back to reference Kalaria RN: Vascular basis for brain degeneration: faltering controls and risk factors for dementia. Nutr Rev. 2010, 68: S74-S87. 10.1111/j.1753-4887.2010.00352.x.PubMedCentralPubMed Kalaria RN: Vascular basis for brain degeneration: faltering controls and risk factors for dementia. Nutr Rev. 2010, 68: S74-S87. 10.1111/j.1753-4887.2010.00352.x.PubMedCentralPubMed
31.
go back to reference Knopman DS, Roberts R: Vascular risk factors: Imaging and neuropathologic correlates. J Alzheimer Dis. 2010, 20: 699-709. Knopman DS, Roberts R: Vascular risk factors: Imaging and neuropathologic correlates. J Alzheimer Dis. 2010, 20: 699-709.
32.
go back to reference Zlokovic BV, Deane R, Sagare AP, Bell RD, Winkler EA: Low-density lipoprotein receptor-related protein-1: a serial clearance homeostatic mechanism controlling Alzheimer's amyloid β-peptide elimination from the brain. J Neurochem. 2010, 115: 1077-1089. 10.1111/j.1471-4159.2010.07002.x.PubMedCentralPubMed Zlokovic BV, Deane R, Sagare AP, Bell RD, Winkler EA: Low-density lipoprotein receptor-related protein-1: a serial clearance homeostatic mechanism controlling Alzheimer's amyloid β-peptide elimination from the brain. J Neurochem. 2010, 115: 1077-1089. 10.1111/j.1471-4159.2010.07002.x.PubMedCentralPubMed
33.
go back to reference Grammas P: A damaged microcirculation contributes to neuronal cell death in Alzheimer's disease. Neurobiol Aging. 2000, 21: 199-205. 10.1016/S0197-4580(00)00102-0.PubMed Grammas P: A damaged microcirculation contributes to neuronal cell death in Alzheimer's disease. Neurobiol Aging. 2000, 21: 199-205. 10.1016/S0197-4580(00)00102-0.PubMed
34.
go back to reference Zuliani G, Cavalieri M, Galvani M, Passaro A, Munari MR, Bosi C, Zurlo A, Fellin R: Markers of endothelial dysfunction in older subjects with late onset Alzheimer's disease or vascular dementia. J Neurol Sci. 2008, 272: 164-170. 10.1016/j.jns.2008.05.020.PubMed Zuliani G, Cavalieri M, Galvani M, Passaro A, Munari MR, Bosi C, Zurlo A, Fellin R: Markers of endothelial dysfunction in older subjects with late onset Alzheimer's disease or vascular dementia. J Neurol Sci. 2008, 272: 164-170. 10.1016/j.jns.2008.05.020.PubMed
35.
go back to reference de la Torre JC: Is Alzheimer's disease a neurodegenerative or a vascular disorder? Data, dogma, and dialectics. Lancet Neurol. 2004, 3: 184-190. 10.1016/S1474-4422(04)00683-0.PubMed de la Torre JC: Is Alzheimer's disease a neurodegenerative or a vascular disorder? Data, dogma, and dialectics. Lancet Neurol. 2004, 3: 184-190. 10.1016/S1474-4422(04)00683-0.PubMed
36.
go back to reference Bell RD, Zlokovic BV: Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease. Acta Neuropathol. 2009, 118: 103-113. 10.1007/s00401-009-0522-3.PubMedCentralPubMed Bell RD, Zlokovic BV: Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease. Acta Neuropathol. 2009, 118: 103-113. 10.1007/s00401-009-0522-3.PubMedCentralPubMed
37.
go back to reference Pakrasi S, O'Brien JT: Emission tomography in dementia. Nucl Med Commun. 2005, 26: 189-196. 10.1097/00006231-200503000-00003.PubMed Pakrasi S, O'Brien JT: Emission tomography in dementia. Nucl Med Commun. 2005, 26: 189-196. 10.1097/00006231-200503000-00003.PubMed
38.
go back to reference Jagust WJ, Bandy D, Chen K, Foster NL, Landau SM, Mathis CA, Price JC, Reiman EM, Skovronsky D, Koeppe RA, Alzheimer's Disease Neuroimaging Initiative: The Alzheimer's Disease Neuroimaging Initiative positron emission tomography core. Alzheimers Dement. 2010, 6: 221-229. 10.1016/j.jalz.2010.03.003.PubMedCentralPubMed Jagust WJ, Bandy D, Chen K, Foster NL, Landau SM, Mathis CA, Price JC, Reiman EM, Skovronsky D, Koeppe RA, Alzheimer's Disease Neuroimaging Initiative: The Alzheimer's Disease Neuroimaging Initiative positron emission tomography core. Alzheimers Dement. 2010, 6: 221-229. 10.1016/j.jalz.2010.03.003.PubMedCentralPubMed
39.
go back to reference Scheibel AB: Changes in brain capillary structure in aging and dementia. Edited by: J Wertheimer and M Marois. 1984, Alan R. Liss, Inc., New York, 137-149. in Senile Dementia Outlook for the Future Scheibel AB: Changes in brain capillary structure in aging and dementia. Edited by: J Wertheimer and M Marois. 1984, Alan R. Liss, Inc., New York, 137-149. in Senile Dementia Outlook for the Future
40.
go back to reference Miyakawa T, Shimoji A, Kumamoto R, Higuchi T: The relationship between senile plaques and cerebral blood vessels in Alzheimer's disease and senile dementia. Morphological mechanism of senile plaque production. Virchows Arch (Cell Pathol). 1982, 40: 121-129. 10.1007/BF02932857. Miyakawa T, Shimoji A, Kumamoto R, Higuchi T: The relationship between senile plaques and cerebral blood vessels in Alzheimer's disease and senile dementia. Morphological mechanism of senile plaque production. Virchows Arch (Cell Pathol). 1982, 40: 121-129. 10.1007/BF02932857.
41.
go back to reference Davies DC, Hardy JA: Blood-brain barrier in aging and Alzheimer's disease. Neurobiol Aging. 1988, 9: 46-48. 10.1016/S0197-4580(88)80017-4.PubMed Davies DC, Hardy JA: Blood-brain barrier in aging and Alzheimer's disease. Neurobiol Aging. 1988, 9: 46-48. 10.1016/S0197-4580(88)80017-4.PubMed
42.
go back to reference Masters CL, Beyreuther K: The blood-brain barrier in Alzheimer's disease and normal aging. Neurobiol Aging. 1988, 9: 43-44. 10.1016/S0197-4580(88)80015-0.PubMed Masters CL, Beyreuther K: The blood-brain barrier in Alzheimer's disease and normal aging. Neurobiol Aging. 1988, 9: 43-44. 10.1016/S0197-4580(88)80015-0.PubMed
43.
go back to reference Araki K, Miyakawa T, Katsuragi S: Ultrastructure of senile plaque using thick sections in the brain with Alzheimer's disease. Jpn J Psychiatry Neurol. 1991, 45: 85-89.PubMed Araki K, Miyakawa T, Katsuragi S: Ultrastructure of senile plaque using thick sections in the brain with Alzheimer's disease. Jpn J Psychiatry Neurol. 1991, 45: 85-89.PubMed
44.
go back to reference de la Torre JC, Mussivand T: Can a disturbed brain microcirculation cause Alzheimer's disease?. Neurol Res. 1993, 15: 146-153.PubMed de la Torre JC, Mussivand T: Can a disturbed brain microcirculation cause Alzheimer's disease?. Neurol Res. 1993, 15: 146-153.PubMed
45.
go back to reference Buee L, Hof PR, Bouras C, Delacourte A, Perl DP, Morrison JH, Fillit HM: Pathological alterations of the cerebral microvasculature in Alzheimer's disease and related dementing disorders. Acta Neuropathol. 1994, 87: 469-480. 10.1007/BF00294173.PubMed Buee L, Hof PR, Bouras C, Delacourte A, Perl DP, Morrison JH, Fillit HM: Pathological alterations of the cerebral microvasculature in Alzheimer's disease and related dementing disorders. Acta Neuropathol. 1994, 87: 469-480. 10.1007/BF00294173.PubMed
46.
go back to reference Dorheim MA, Tracey WR, Pollock JS, Grammas P: Nitric oxide is elevated in Alzheimer's brain microvessels. Biochem Biophys Res Comm. 1994, 205: 659-665. 10.1006/bbrc.1994.2716.PubMed Dorheim MA, Tracey WR, Pollock JS, Grammas P: Nitric oxide is elevated in Alzheimer's brain microvessels. Biochem Biophys Res Comm. 1994, 205: 659-665. 10.1006/bbrc.1994.2716.PubMed
47.
go back to reference Kalaria RN, Hedera P: Differential degeneration of the cerebral microvasculature in Alzheimer's disease. NeuroReport. 1995, 6: 477-480. 10.1097/00001756-199502000-00018.PubMed Kalaria RN, Hedera P: Differential degeneration of the cerebral microvasculature in Alzheimer's disease. NeuroReport. 1995, 6: 477-480. 10.1097/00001756-199502000-00018.PubMed
48.
go back to reference Kalaria RN, Pax AB: Increased collagen content of cerebral microvessels in Alzheimer's disease. Brain Res. 1995, 705: 349-352. 10.1016/0006-8993(95)01250-8.PubMed Kalaria RN, Pax AB: Increased collagen content of cerebral microvessels in Alzheimer's disease. Brain Res. 1995, 705: 349-352. 10.1016/0006-8993(95)01250-8.PubMed
49.
go back to reference Kalaria RN: Cerebral vessels in aging and Alzheimer's disease. Pharmacol Ther. 1996, 72: 193-214. 10.1016/S0163-7258(96)00116-7.PubMed Kalaria RN: Cerebral vessels in aging and Alzheimer's disease. Pharmacol Ther. 1996, 72: 193-214. 10.1016/S0163-7258(96)00116-7.PubMed
50.
go back to reference Claudio L: Ultrastructural features of the blood-brain barrier in biopsy tissue from Alzheimer's disease patients. Acta Neuropathol. 1996, 91: 6-14. 10.1007/s004010050386.PubMed Claudio L: Ultrastructural features of the blood-brain barrier in biopsy tissue from Alzheimer's disease patients. Acta Neuropathol. 1996, 91: 6-14. 10.1007/s004010050386.PubMed
51.
go back to reference de la Torre JC: Cerebromicrovascular pathology in Alzheimer's disease compared to normal aging. Gerontology. 1997, 43: 26-43. 10.1159/000213834.PubMed de la Torre JC: Cerebromicrovascular pathology in Alzheimer's disease compared to normal aging. Gerontology. 1997, 43: 26-43. 10.1159/000213834.PubMed
52.
go back to reference Grammas P, Moore P, Weigel PH: Microvessels from Alzheimer's disease brain kill neurons in vitro. Am J Pathol. 1999, 154: 337-342. 10.1016/S0002-9440(10)65280-7.PubMedCentralPubMed Grammas P, Moore P, Weigel PH: Microvessels from Alzheimer's disease brain kill neurons in vitro. Am J Pathol. 1999, 154: 337-342. 10.1016/S0002-9440(10)65280-7.PubMedCentralPubMed
53.
go back to reference Farkas E, Luiten PG: Cerebral microvascular pathology in aging and Alzheimer's disease. Prog Neurobiol. 2001, 64: 575-611. 10.1016/S0301-0082(00)00068-X.PubMed Farkas E, Luiten PG: Cerebral microvascular pathology in aging and Alzheimer's disease. Prog Neurobiol. 2001, 64: 575-611. 10.1016/S0301-0082(00)00068-X.PubMed
54.
go back to reference Grammas P, Ovase R: Inflammatory factors are elevated in brain microvessels in Alzheimer's disease. Neurobiol Aging. 2001, 22: 837-842. 10.1016/S0197-4580(01)00276-7.PubMed Grammas P, Ovase R: Inflammatory factors are elevated in brain microvessels in Alzheimer's disease. Neurobiol Aging. 2001, 22: 837-842. 10.1016/S0197-4580(01)00276-7.PubMed
55.
go back to reference Grammas P, Ovase R: Cerebrovascular TGF-β contributes to inflammation in the Alzheimer's brain. Am J Pathol. 2002, 160: 1583-1587. 10.1016/S0002-9440(10)61105-4.PubMedCentralPubMed Grammas P, Ovase R: Cerebrovascular TGF-β contributes to inflammation in the Alzheimer's brain. Am J Pathol. 2002, 160: 1583-1587. 10.1016/S0002-9440(10)61105-4.PubMedCentralPubMed
56.
go back to reference Christov A, Ottman T, Hamdheydari L, Grammas P: Structural changes in Alzheimer's disease brain microvessels. Current Alz Res. 2008, 5: 392-395. 10.2174/156720508785132334. Christov A, Ottman T, Hamdheydari L, Grammas P: Structural changes in Alzheimer's disease brain microvessels. Current Alz Res. 2008, 5: 392-395. 10.2174/156720508785132334.
57.
go back to reference Meyer EP, Ulmann-Schuler A, Staufenbiel M, Krucker T: Altered morphology and 3D architecture of brain vasculature in a mouse model for Alzheimer's disease. Proc Natl Acad Sci USA. 2008, 105: 3587-3592. 10.1073/pnas.0709788105.PubMedCentralPubMed Meyer EP, Ulmann-Schuler A, Staufenbiel M, Krucker T: Altered morphology and 3D architecture of brain vasculature in a mouse model for Alzheimer's disease. Proc Natl Acad Sci USA. 2008, 105: 3587-3592. 10.1073/pnas.0709788105.PubMedCentralPubMed
58.
go back to reference Duong T, Nikolaeva M, Acton PJ: C-reactive protein-like immunoreactivity in the neurofibrillary tangles of Alzheimer's disease. Brain Res. 1997, 749: 152-156. 10.1016/S0006-8993(96)01359-5.PubMed Duong T, Nikolaeva M, Acton PJ: C-reactive protein-like immunoreactivity in the neurofibrillary tangles of Alzheimer's disease. Brain Res. 1997, 749: 152-156. 10.1016/S0006-8993(96)01359-5.PubMed
59.
go back to reference Cleland SJ, Sattar N, Petrie JR, Forouhi NG, Elliott HL, Connell JM: Endothelial dysfunction as a possible link between C-reactive protein levels and cardiovascular disease. Clin Sci. 2000, 988: 531-535. 10.1042/CS20000013. Cleland SJ, Sattar N, Petrie JR, Forouhi NG, Elliott HL, Connell JM: Endothelial dysfunction as a possible link between C-reactive protein levels and cardiovascular disease. Clin Sci. 2000, 988: 531-535. 10.1042/CS20000013.
60.
go back to reference Fay WP: Linking inflammation and thrombosis: Role of C-reactive protein. World J Cardiol. 2010, 2: 365-369. 10.4330/wjc.v2.i11.365.PubMedCentralPubMed Fay WP: Linking inflammation and thrombosis: Role of C-reactive protein. World J Cardiol. 2010, 2: 365-369. 10.4330/wjc.v2.i11.365.PubMedCentralPubMed
61.
go back to reference Ross R: Atherosclerosis--an inflammatory disease. N Engl J Med. 1999, 340: 115-126. 10.1056/NEJM199901143400207.PubMed Ross R: Atherosclerosis--an inflammatory disease. N Engl J Med. 1999, 340: 115-126. 10.1056/NEJM199901143400207.PubMed
62.
go back to reference De Caterina R, Massaro M, Scoditti E, Annunziata Carluccio M: Pharmacological modulation of vascular inflammation in atherothrombosis. Ann NY Acad Sci. 2010, 1207: 23-31. 10.1111/j.1749-6632.2010.05784.x.PubMed De Caterina R, Massaro M, Scoditti E, Annunziata Carluccio M: Pharmacological modulation of vascular inflammation in atherothrombosis. Ann NY Acad Sci. 2010, 1207: 23-31. 10.1111/j.1749-6632.2010.05784.x.PubMed
63.
go back to reference Glass CK, Saijo K, Winner B, Marchetto MC, Gage FH: Mechanisms underlying inflammation in neurodegeneration. Cell. 2010, 140: 918-934. 10.1016/j.cell.2010.02.016.PubMedCentralPubMed Glass CK, Saijo K, Winner B, Marchetto MC, Gage FH: Mechanisms underlying inflammation in neurodegeneration. Cell. 2010, 140: 918-934. 10.1016/j.cell.2010.02.016.PubMedCentralPubMed
64.
go back to reference Cooper NR, Bradt BM, O'Barr S, Yu JX: Focal inflammation in the brain: role in Alzheimer's disease. Immunol Res. 2000, 21: 159-165. 10.1385/IR:21:2-3:159.PubMed Cooper NR, Bradt BM, O'Barr S, Yu JX: Focal inflammation in the brain: role in Alzheimer's disease. Immunol Res. 2000, 21: 159-165. 10.1385/IR:21:2-3:159.PubMed
65.
go back to reference Neuroinflammation Working Group: Inflammation and Alzheimer's disease. Neurobiol Aging. 2000, 21: 383-421. 10.1016/S0197-4580(00)00124-X.PubMedCentral Neuroinflammation Working Group: Inflammation and Alzheimer's disease. Neurobiol Aging. 2000, 21: 383-421. 10.1016/S0197-4580(00)00124-X.PubMedCentral
66.
go back to reference Tarkowski E: Cytokines in dementia. Curr Drug Targets Inflamm Allergy. 2002, 1: 193-200. 10.2174/1568010023344670.PubMed Tarkowski E: Cytokines in dementia. Curr Drug Targets Inflamm Allergy. 2002, 1: 193-200. 10.2174/1568010023344670.PubMed
67.
go back to reference McGeer EG, McGeer PL: Inflammatory processes in Alzheimer's disease. Prog Neuropsycholpharmacol Biol Psychiatry. 2003, 27: 741-749. 10.1016/S0278-5846(03)00124-6. McGeer EG, McGeer PL: Inflammatory processes in Alzheimer's disease. Prog Neuropsycholpharmacol Biol Psychiatry. 2003, 27: 741-749. 10.1016/S0278-5846(03)00124-6.
68.
go back to reference McGeer PL, McGeer EG: Inflammation and the degenerative diseases of aging. Ann NY Acad Sci. 2004, 1035: 104-116. 10.1196/annals.1332.007.PubMed McGeer PL, McGeer EG: Inflammation and the degenerative diseases of aging. Ann NY Acad Sci. 2004, 1035: 104-116. 10.1196/annals.1332.007.PubMed
69.
go back to reference Ho GJ, Drego R, Hakimian E, Masliah E: Mechanisms of cell signaling and inflammation in Alzheimer's disease. Curr Drug Targets Inflamm Allergy. 2005, 4: 247-256. 10.2174/1568010053586237.PubMed Ho GJ, Drego R, Hakimian E, Masliah E: Mechanisms of cell signaling and inflammation in Alzheimer's disease. Curr Drug Targets Inflamm Allergy. 2005, 4: 247-256. 10.2174/1568010053586237.PubMed
70.
go back to reference Wyss-Coray T: Inflammation in Alzheimer disease: driving force, bystander or beneficial response?. Nat Med. 2006, 12: 1005-1015.PubMed Wyss-Coray T: Inflammation in Alzheimer disease: driving force, bystander or beneficial response?. Nat Med. 2006, 12: 1005-1015.PubMed
71.
go back to reference Lee YJ, Han SB, Nam SY, Oh KW, Hong JT: Inflammation and Alzheimer's disease. Arch Pharm Res. 2010, 33: 1539-155. 10.1007/s12272-010-1006-7.PubMed Lee YJ, Han SB, Nam SY, Oh KW, Hong JT: Inflammation and Alzheimer's disease. Arch Pharm Res. 2010, 33: 1539-155. 10.1007/s12272-010-1006-7.PubMed
72.
go back to reference Lee DC, Rizer J, Selenica M-LB, Reid P, Kraft C, Johnson A, Blair L, Gordon MN, Dickey CA, Morgan D: LPS-induced inflammation exacerbates phospho-tau pathology in rTg4510 mice. J Neuroinflammation. 2010, 7: 56-10.1186/1742-2094-7-56.PubMedCentralPubMed Lee DC, Rizer J, Selenica M-LB, Reid P, Kraft C, Johnson A, Blair L, Gordon MN, Dickey CA, Morgan D: LPS-induced inflammation exacerbates phospho-tau pathology in rTg4510 mice. J Neuroinflammation. 2010, 7: 56-10.1186/1742-2094-7-56.PubMedCentralPubMed
73.
go back to reference McGeer PL, Schulzer M, McGeer EG: Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies. Neurology. 1996, 47: 425-432.PubMed McGeer PL, Schulzer M, McGeer EG: Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies. Neurology. 1996, 47: 425-432.PubMed
74.
go back to reference Stewart WF, Kawas C, Corrada M, Metter EJ: Risk of Alzheimer's disease and duration of NSAID use. Neurology. 1997, 48: 626-632.PubMed Stewart WF, Kawas C, Corrada M, Metter EJ: Risk of Alzheimer's disease and duration of NSAID use. Neurology. 1997, 48: 626-632.PubMed
75.
go back to reference Hayden KM, Zandi PP, Khachaturian AS, Szekely CA, Fotuhi M, Norton MC, Tschanz JT, Pieper CF, Corcoran C, Lyketsos CG, Breitner JC, Welsh-Bohmer KA, Cache County Investigators: Does NSAID use modify cognitive trajectories in the elderly? The Cache County study. Neurology. 2007, 69: 275-282. 10.1212/01.wnl.0000265223.25679.2a.PubMed Hayden KM, Zandi PP, Khachaturian AS, Szekely CA, Fotuhi M, Norton MC, Tschanz JT, Pieper CF, Corcoran C, Lyketsos CG, Breitner JC, Welsh-Bohmer KA, Cache County Investigators: Does NSAID use modify cognitive trajectories in the elderly? The Cache County study. Neurology. 2007, 69: 275-282. 10.1212/01.wnl.0000265223.25679.2a.PubMed
76.
go back to reference Vlad SC, Miller DR, Kowall NW, Feson DT: Protective effects of NSAIDs on the development of Alzheimer's disease. Neurology. 2008, 70: 1672-1677. 10.1212/01.wnl.0000311269.57716.63.PubMedCentralPubMed Vlad SC, Miller DR, Kowall NW, Feson DT: Protective effects of NSAIDs on the development of Alzheimer's disease. Neurology. 2008, 70: 1672-1677. 10.1212/01.wnl.0000311269.57716.63.PubMedCentralPubMed
77.
go back to reference Pasinetti GML: From epidemiology to therapeutic trials with anti-inflammatory drugs in Alzheimer's disease: the role of NSAIDs and cyclooxygenase in beta-amyloidosis and clinical dementia. J Alzheimers Dis. 2002, 4: 435-445.PubMed Pasinetti GML: From epidemiology to therapeutic trials with anti-inflammatory drugs in Alzheimer's disease: the role of NSAIDs and cyclooxygenase in beta-amyloidosis and clinical dementia. J Alzheimers Dis. 2002, 4: 435-445.PubMed
78.
go back to reference Lim GP, Yang F, Chu T, Chen P, Beech W, Teter B, Tran T, Ubeda O, Ashe KH, Frautschy SA, Cole GM: Ibuprofen suppresses plaque pathology and inflammation in a mouse model for Alzheimer's disease. J Neurosci. 2000, 20: 5709-5714.PubMed Lim GP, Yang F, Chu T, Chen P, Beech W, Teter B, Tran T, Ubeda O, Ashe KH, Frautschy SA, Cole GM: Ibuprofen suppresses plaque pathology and inflammation in a mouse model for Alzheimer's disease. J Neurosci. 2000, 20: 5709-5714.PubMed
79.
go back to reference Lim GP, Yang F, Chu T, Gahtan E, Ubeda O, Beech W, Overmier JB, Hsiao-Ashec K, Frautschy SA, Cole GM: Ibuprofen effects on Alzheimer pathology and open field activity in APPsw transgenic mice. Neurobiol Aging. 2001, 22: 983-991. 10.1016/S0197-4580(01)00299-8.PubMed Lim GP, Yang F, Chu T, Gahtan E, Ubeda O, Beech W, Overmier JB, Hsiao-Ashec K, Frautschy SA, Cole GM: Ibuprofen effects on Alzheimer pathology and open field activity in APPsw transgenic mice. Neurobiol Aging. 2001, 22: 983-991. 10.1016/S0197-4580(01)00299-8.PubMed
80.
go back to reference Etminan M, Gill S, Samii A: Effect of non-steroidal anti-inflammatory drugs on risk of Alzheimer's disease: systematic review and meta-analysis of observational studies. BMJ. 2003, 327: 128-10.1136/bmj.327.7407.128.PubMedCentralPubMed Etminan M, Gill S, Samii A: Effect of non-steroidal anti-inflammatory drugs on risk of Alzheimer's disease: systematic review and meta-analysis of observational studies. BMJ. 2003, 327: 128-10.1136/bmj.327.7407.128.PubMedCentralPubMed
81.
go back to reference Yan Q, Zhang J, Liu H, Babu-Khan S, Vassar R, Biere AL, Citron M, Landreth G: Anti-inflammatory drug therapy alters beta-amyloid processing and deposition in an animal model of Alzheimer's disease. J Neurosci. 2003, 23: 7504-7509.PubMed Yan Q, Zhang J, Liu H, Babu-Khan S, Vassar R, Biere AL, Citron M, Landreth G: Anti-inflammatory drug therapy alters beta-amyloid processing and deposition in an animal model of Alzheimer's disease. J Neurosci. 2003, 23: 7504-7509.PubMed
82.
go back to reference Kotilinek LA, Westerman MA, Wang Q, Panizzon K, Lim GP, Simonyi A, Lesne S, Falinska A, Younkin LH, Younkin SG, Rowan M, Cleary J, Wallis RA, Sun GY, Cole G, Frautschy S, Anwyl R, Ashe KH: Cyclooxygenase-2 inhibition improves amyloid-beta-mediated suppression of memory and synaptic plasticity. Brain. 2008, 131: 651-664. 10.1093/brain/awn008.PubMedCentralPubMed Kotilinek LA, Westerman MA, Wang Q, Panizzon K, Lim GP, Simonyi A, Lesne S, Falinska A, Younkin LH, Younkin SG, Rowan M, Cleary J, Wallis RA, Sun GY, Cole G, Frautschy S, Anwyl R, Ashe KH: Cyclooxygenase-2 inhibition improves amyloid-beta-mediated suppression of memory and synaptic plasticity. Brain. 2008, 131: 651-664. 10.1093/brain/awn008.PubMedCentralPubMed
83.
go back to reference Szekely CA, Thorne JE, Zandi PP, Ek M, Messias E, Breitner JC, Goodman SN: Nonsteroidal anti-inflammatory drugs for the prevention of Alzheimer's disease: a systematic review. Neuroepidemiology. 2004, 23: 159-169. 10.1159/000078501.PubMed Szekely CA, Thorne JE, Zandi PP, Ek M, Messias E, Breitner JC, Goodman SN: Nonsteroidal anti-inflammatory drugs for the prevention of Alzheimer's disease: a systematic review. Neuroepidemiology. 2004, 23: 159-169. 10.1159/000078501.PubMed
84.
go back to reference Aisen PS, Schafer KA, Grundman M, Pfeiffer E, Sano M, Davis KL, Farlow MR, Jin S, Thomas RG, Thal LJ, Alzheimer's Disease Cooperative Study: Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized clinical trial. JAMA. 2003, 289: 2819-2826. 10.1001/jama.289.21.2819.PubMed Aisen PS, Schafer KA, Grundman M, Pfeiffer E, Sano M, Davis KL, Farlow MR, Jin S, Thomas RG, Thal LJ, Alzheimer's Disease Cooperative Study: Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized clinical trial. JAMA. 2003, 289: 2819-2826. 10.1001/jama.289.21.2819.PubMed
85.
go back to reference Green RD, Schneider LS, Hendrix SB, Zavitz KH, Swabb E: Safety and efficacy of tarenflurbil in subjects with mild Alzheimer's disease: results from an 18-month multi-center phase 3 trial. Alzheimers Dement. 2008, 4 (Suppl): T165-10.1016/j.jalz.2008.05.432. Green RD, Schneider LS, Hendrix SB, Zavitz KH, Swabb E: Safety and efficacy of tarenflurbil in subjects with mild Alzheimer's disease: results from an 18-month multi-center phase 3 trial. Alzheimers Dement. 2008, 4 (Suppl): T165-10.1016/j.jalz.2008.05.432.
86.
go back to reference ADAPT Research Group, Martin BK, Szekely C, Brandt J, Piantadosi S, Breitner JC, Craft S, Evans D, Green R, Mullan M: Cognitive function over time in the Alzheimer's Disease Anti-Inflammatory Prevention Trial (ADAPT): results of a randomized, controlled trial of naproxen and celecoxib. Arch Neurol. 2008, 896-905. ADAPT Research Group, Martin BK, Szekely C, Brandt J, Piantadosi S, Breitner JC, Craft S, Evans D, Green R, Mullan M: Cognitive function over time in the Alzheimer's Disease Anti-Inflammatory Prevention Trial (ADAPT): results of a randomized, controlled trial of naproxen and celecoxib. Arch Neurol. 2008, 896-905.
87.
go back to reference Zandi PP, Anthony JC, Hayden KM, Mehta K, Mayer L, Breitner JC, Cache County Study Investigators: Reduced incidence of AD with NSAID but not H2 receptor antagonists: the Cache County Study. Neurology. 2002, 59: 880-886.PubMed Zandi PP, Anthony JC, Hayden KM, Mehta K, Mayer L, Breitner JC, Cache County Study Investigators: Reduced incidence of AD with NSAID but not H2 receptor antagonists: the Cache County Study. Neurology. 2002, 59: 880-886.PubMed
88.
go back to reference Varvel NH, Bhasker K, Kounnas MZ, Wagner SL, Yang Y, Lamb BT, Herrup K: NSAIDS prevent, but do not reverse, neuronal cell cycle reentry in a mouse model of Alzheimer disease. J Clin Invest. 2009, 119: 3692-3701. 10.1172/JCI39716.PubMedCentralPubMed Varvel NH, Bhasker K, Kounnas MZ, Wagner SL, Yang Y, Lamb BT, Herrup K: NSAIDS prevent, but do not reverse, neuronal cell cycle reentry in a mouse model of Alzheimer disease. J Clin Invest. 2009, 119: 3692-3701. 10.1172/JCI39716.PubMedCentralPubMed
89.
go back to reference Tehranian R, Hasanvan H, Iverfeldt K, Post C, Schultzberg M: Early induction of interleukin-6 mRNA in the hippocampus and cortex of APPsw transgenic mice Tg2576. Neurosci Lett. 2001, 301: 54-58. 10.1016/S0304-3940(01)01592-0.PubMed Tehranian R, Hasanvan H, Iverfeldt K, Post C, Schultzberg M: Early induction of interleukin-6 mRNA in the hippocampus and cortex of APPsw transgenic mice Tg2576. Neurosci Lett. 2001, 301: 54-58. 10.1016/S0304-3940(01)01592-0.PubMed
90.
go back to reference Janelsins MC, Mastrangelo MA, Oddo S, LaFerla FM, Federoff HJ, Bowers WJ: Early correlation of microglial activationwith enhanced tumor necrosis factor-alpha and monocyte chemoattractant protein-1 expression specifically within the entorhinal cortex of triple transgenic Alzheimer's disease mice. J Neuroinflammation. 2005, 2: 23-10.1186/1742-2094-2-23.PubMedCentralPubMed Janelsins MC, Mastrangelo MA, Oddo S, LaFerla FM, Federoff HJ, Bowers WJ: Early correlation of microglial activationwith enhanced tumor necrosis factor-alpha and monocyte chemoattractant protein-1 expression specifically within the entorhinal cortex of triple transgenic Alzheimer's disease mice. J Neuroinflammation. 2005, 2: 23-10.1186/1742-2094-2-23.PubMedCentralPubMed
91.
go back to reference Frohman EM, Frohman TC, Gupta S, de Fourgerolles A, van den Noort S: Expression of intercellular adhesion molecule 1 (ICAM-1) in Alzheimer's disease. J Neuro Sci. 1991, 106: 105-111. 10.1016/0022-510X(91)90202-I. Frohman EM, Frohman TC, Gupta S, de Fourgerolles A, van den Noort S: Expression of intercellular adhesion molecule 1 (ICAM-1) in Alzheimer's disease. J Neuro Sci. 1991, 106: 105-111. 10.1016/0022-510X(91)90202-I.
92.
go back to reference Pereira HA, Kumar P, Grammas P: Expression of CAP37, a novel inflammatory mediator, in Alzheimer's disease. Neurobiol Aging. 1996, 17: 753-759. 10.1016/S0197-4580(96)00118-2.PubMed Pereira HA, Kumar P, Grammas P: Expression of CAP37, a novel inflammatory mediator, in Alzheimer's disease. Neurobiol Aging. 1996, 17: 753-759. 10.1016/S0197-4580(96)00118-2.PubMed
93.
go back to reference Thirumangalakudi L, Samany PG, Owoso A, Wiskar B, Grammas P: Angiogenic proteins are expressed by brain blood vessels in Alzheimer's disease. J Alzheimers Dis. 2006, 10: 111-118.PubMed Thirumangalakudi L, Samany PG, Owoso A, Wiskar B, Grammas P: Angiogenic proteins are expressed by brain blood vessels in Alzheimer's disease. J Alzheimers Dis. 2006, 10: 111-118.PubMed
94.
go back to reference Li M, Shang DS, Zhao WD, Tian L, Li B, Fang WG, Zhu L, Man SM, Chen YH: Amyloid beta interaction with receptor for advanced glycation end products up-regulates brain endothelial CCR5 expression and promotes T cells crossing the blood-brain barrier. J Immunol. 2009, 182: 5778-5788. 10.4049/jimmunol.0803013.PubMed Li M, Shang DS, Zhao WD, Tian L, Li B, Fang WG, Zhu L, Man SM, Chen YH: Amyloid beta interaction with receptor for advanced glycation end products up-regulates brain endothelial CCR5 expression and promotes T cells crossing the blood-brain barrier. J Immunol. 2009, 182: 5778-5788. 10.4049/jimmunol.0803013.PubMed
95.
go back to reference Deane R, Yan SD, Submamaryan RK, LaRue B, Jovanovic S, Hogg E, Welch D, Manness L, Lin C, Yu J, Zhu H, Ghiso J, Frangione F, Stern A, Schmidt AM, Armstrong DL, Arnold B, Liliensiek B, Nawroth P, Hofman F, Kindy M, Stern D, Zlokovic B: RAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brain. Nat Med. 2003, 9: 907-913. 10.1038/nm890.PubMed Deane R, Yan SD, Submamaryan RK, LaRue B, Jovanovic S, Hogg E, Welch D, Manness L, Lin C, Yu J, Zhu H, Ghiso J, Frangione F, Stern A, Schmidt AM, Armstrong DL, Arnold B, Liliensiek B, Nawroth P, Hofman F, Kindy M, Stern D, Zlokovic B: RAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brain. Nat Med. 2003, 9: 907-913. 10.1038/nm890.PubMed
96.
go back to reference Vukic V, Callaghan D, Walker D, Lue LF, Liu QY, Couraud PO, Romero IA, Weksler B, Stanimirovic DB, Zhang W: Expression of inflammatory genes induced by beta-amyloid peptides in human brain endothelial cells and in Alzheimer's brain is mediated by the JNK-AP1 signaling pathway. Neurobiol Dis. 2009, 34: 95-106. 10.1016/j.nbd.2008.12.007.PubMedCentralPubMed Vukic V, Callaghan D, Walker D, Lue LF, Liu QY, Couraud PO, Romero IA, Weksler B, Stanimirovic DB, Zhang W: Expression of inflammatory genes induced by beta-amyloid peptides in human brain endothelial cells and in Alzheimer's brain is mediated by the JNK-AP1 signaling pathway. Neurobiol Dis. 2009, 34: 95-106. 10.1016/j.nbd.2008.12.007.PubMedCentralPubMed
97.
go back to reference Paris D, Townsend KP, Obregon DF, Humphrey j, Mullan M: Pro-inflammatory effort of freshly solubilized beta-amyloid peptides in the brain. Prostaglandins Other Lipid Mediat. 2002, 70: 1-12. 10.1016/S0090-6980(02)00111-9.PubMed Paris D, Townsend KP, Obregon DF, Humphrey j, Mullan M: Pro-inflammatory effort of freshly solubilized beta-amyloid peptides in the brain. Prostaglandins Other Lipid Mediat. 2002, 70: 1-12. 10.1016/S0090-6980(02)00111-9.PubMed
98.
go back to reference Suo Z, Tan J, Placzek A, Crawford F, Fang C, Mullan M: Alzheimer's beta-amyloid peptides induce inflammatory cascade in human vascular cells: the roles of cytokines and CD40. Brain Res. 1998, 807: 110-117. 10.1016/S0006-8993(98)00780-X.PubMed Suo Z, Tan J, Placzek A, Crawford F, Fang C, Mullan M: Alzheimer's beta-amyloid peptides induce inflammatory cascade in human vascular cells: the roles of cytokines and CD40. Brain Res. 1998, 807: 110-117. 10.1016/S0006-8993(98)00780-X.PubMed
99.
go back to reference Poveshchenko AF, Konenkov VI: Mechanisms and factors of angiogenesis. Usp Fiziol Nauk. 2010, 41: 68-89.PubMed Poveshchenko AF, Konenkov VI: Mechanisms and factors of angiogenesis. Usp Fiziol Nauk. 2010, 41: 68-89.PubMed
100.
go back to reference Sgambato A, Cittadini A: Inflammation and cancer: a multifaceted link. Eur Rev Med Pharmacol Sci. 2010, 14: 263-268.PubMed Sgambato A, Cittadini A: Inflammation and cancer: a multifaceted link. Eur Rev Med Pharmacol Sci. 2010, 14: 263-268.PubMed
101.
go back to reference Pogue AI, Lukiw WJ: Angiogenic signaling in Alzheimer's disease. Neuroreport. 2004, 15: 1507-1510. 10.1097/01.wnr.0000130539.39937.1d.PubMed Pogue AI, Lukiw WJ: Angiogenic signaling in Alzheimer's disease. Neuroreport. 2004, 15: 1507-1510. 10.1097/01.wnr.0000130539.39937.1d.PubMed
102.
go back to reference Miklossy J: Cerebral hypoperfusion induces cortical watershed microinfarcts which may further aggravate cognitive decline in Alzheimer's disease. Neurol Res. 2003, 25: 605-610. 10.1179/016164103101202048.PubMed Miklossy J: Cerebral hypoperfusion induces cortical watershed microinfarcts which may further aggravate cognitive decline in Alzheimer's disease. Neurol Res. 2003, 25: 605-610. 10.1179/016164103101202048.PubMed
103.
go back to reference Pugh CW, Ratcliffe PJ: Regulation of angiogenesis by hypoxia: role of the HIF system. Nat Med. 2003, 9: 677-684. 10.1038/nm0603-677.PubMed Pugh CW, Ratcliffe PJ: Regulation of angiogenesis by hypoxia: role of the HIF system. Nat Med. 2003, 9: 677-684. 10.1038/nm0603-677.PubMed
104.
go back to reference Yamakawa M, Liu LX, Date T, Belanger AJ, Vincent KA, Akita GY, Kuriyama T, Cheng SH: Hypoxia-inducible factor-1 mediates activation of cultured vascular endothelial cells by inducing multiple angiogenic factors. Circ Res. 2003, 93: 664-673. 10.1161/01.RES.0000093984.48643.D7.PubMed Yamakawa M, Liu LX, Date T, Belanger AJ, Vincent KA, Akita GY, Kuriyama T, Cheng SH: Hypoxia-inducible factor-1 mediates activation of cultured vascular endothelial cells by inducing multiple angiogenic factors. Circ Res. 2003, 93: 664-673. 10.1161/01.RES.0000093984.48643.D7.PubMed
105.
go back to reference Kalaria RN, Cohen DL, Premkumar DR, Nag S, LaManna JC, Lust WD: Vascular endothelial growth factor in Alzheimer's disease and experimental ischemia. Brain Res Mol Brain Res. 1998, 62: 101-105. 10.1016/S0169-328X(98)00190-9.PubMed Kalaria RN, Cohen DL, Premkumar DR, Nag S, LaManna JC, Lust WD: Vascular endothelial growth factor in Alzheimer's disease and experimental ischemia. Brain Res Mol Brain Res. 1998, 62: 101-105. 10.1016/S0169-328X(98)00190-9.PubMed
106.
go back to reference Tarkowski E, Issa R, Sjogren M, Wallin A, Blennow K, Tarkowski A, Kumar P: Increased intrathecal levels of the angiogenic factors VEGF and TGF-beta in Alzheimer's disease and vascular dementia. Neurobiol Aging. 2002, 23: 237-243. 10.1016/S0197-4580(01)00285-8.PubMed Tarkowski E, Issa R, Sjogren M, Wallin A, Blennow K, Tarkowski A, Kumar P: Increased intrathecal levels of the angiogenic factors VEGF and TGF-beta in Alzheimer's disease and vascular dementia. Neurobiol Aging. 2002, 23: 237-243. 10.1016/S0197-4580(01)00285-8.PubMed
107.
go back to reference Del Bo R, Ghezzi S, Scarpini E, Bresolin N, Comi GP: VEGF genetic variability is associated with increased risk of developing Alzheimer's disease. J Neurol Sci. 2009, 283: 66-68. 10.1016/j.jns.2009.02.318.PubMed Del Bo R, Ghezzi S, Scarpini E, Bresolin N, Comi GP: VEGF genetic variability is associated with increased risk of developing Alzheimer's disease. J Neurol Sci. 2009, 283: 66-68. 10.1016/j.jns.2009.02.318.PubMed
108.
go back to reference Grammas P, Ghatreh-Samany P, Thirmangalakudi L: Thrombin and Inflammatory proteins are elevated in Alzheimer's disease microvessels: Implications for disease pathogenesis. J Alzheimer Dis. 2006, 9: 51-58. Grammas P, Ghatreh-Samany P, Thirmangalakudi L: Thrombin and Inflammatory proteins are elevated in Alzheimer's disease microvessels: Implications for disease pathogenesis. J Alzheimer Dis. 2006, 9: 51-58.
109.
go back to reference Yin X, Wright J, Wall T, Grammas P: Brain endothelial cells synthesize neurotoxic thrombin in Alzheimer's disease. Am J Pathol. 2010, 176: 1600-1606. 10.2353/ajpath.2010.090406.PubMedCentralPubMed Yin X, Wright J, Wall T, Grammas P: Brain endothelial cells synthesize neurotoxic thrombin in Alzheimer's disease. Am J Pathol. 2010, 176: 1600-1606. 10.2353/ajpath.2010.090406.PubMedCentralPubMed
110.
go back to reference Lukiw WJ, Ottlecz A, Lambrou G, Grueninger M, Finely J, Thompson HW, Bazan NG: Coordinate activation of HIF-1 and NF-kappaB DNA binding and COX-2 and VEGF expression in retinal cells by hypoxia. Invest Ophthalmol Vis Sci. 2003, 44: 4163-4170. 10.1167/iovs.02-0655.PubMed Lukiw WJ, Ottlecz A, Lambrou G, Grueninger M, Finely J, Thompson HW, Bazan NG: Coordinate activation of HIF-1 and NF-kappaB DNA binding and COX-2 and VEGF expression in retinal cells by hypoxia. Invest Ophthalmol Vis Sci. 2003, 44: 4163-4170. 10.1167/iovs.02-0655.PubMed
111.
go back to reference Jellinger KA: Alzheimer disease and cerebrovascular pathology: an update. J Neural Transm. 2002, 109: 813-836. 10.1007/s007020200068.PubMed Jellinger KA: Alzheimer disease and cerebrovascular pathology: an update. J Neural Transm. 2002, 109: 813-836. 10.1007/s007020200068.PubMed
112.
go back to reference Buee L, Hof PR, Delacourte A: Brain microvascular changes in Alzheimer's disease and other dementias. Ann NY Acad Sci. 1997, 826: 7-24. 10.1111/j.1749-6632.1997.tb48457.x.PubMed Buee L, Hof PR, Delacourte A: Brain microvascular changes in Alzheimer's disease and other dementias. Ann NY Acad Sci. 1997, 826: 7-24. 10.1111/j.1749-6632.1997.tb48457.x.PubMed
113.
go back to reference Edelber JM, Reed MJ: Aging and angiogenesis. Front Biosci. 2003, 8: s1199-s1209. 10.2741/1166. Edelber JM, Reed MJ: Aging and angiogenesis. Front Biosci. 2003, 8: s1199-s1209. 10.2741/1166.
114.
go back to reference Paris D, Townsend K, Quadros A, Humphrey J, Sun J, Brem S, Wotoczek-Obadia M, DelleDonne A, Patel N, Obregon DF, Crescentini R, Abdullah L, Coppola D, Rojiani AM, Crawford F, Sebti SM, Mullan M: Inhibition of angiogenesis by Aβ peptides. Angiogenesis. 2004, 7: 75-85. 10.1023/B:AGEN.0000037335.17717.bf.PubMed Paris D, Townsend K, Quadros A, Humphrey J, Sun J, Brem S, Wotoczek-Obadia M, DelleDonne A, Patel N, Obregon DF, Crescentini R, Abdullah L, Coppola D, Rojiani AM, Crawford F, Sebti SM, Mullan M: Inhibition of angiogenesis by Aβ peptides. Angiogenesis. 2004, 7: 75-85. 10.1023/B:AGEN.0000037335.17717.bf.PubMed
115.
go back to reference Paris D, Patel N, DelleDonne A, Quadros A, Smeed R, Mullan M: Impaired angiogenesis in a transgenic mouse model of cerebral amyloidosis. Neurosci Lett. 2004, 366: 80-85. 10.1016/j.neulet.2004.05.017.PubMed Paris D, Patel N, DelleDonne A, Quadros A, Smeed R, Mullan M: Impaired angiogenesis in a transgenic mouse model of cerebral amyloidosis. Neurosci Lett. 2004, 366: 80-85. 10.1016/j.neulet.2004.05.017.PubMed
116.
go back to reference Paris D, Ait-Ghezala G, Mathura VS, Patel N, Quadros A: Anti-angiogenic activity of the mutant Dutch Aβ peptide on human brain microvascular endothelial cells. Mol Brain Res. 2005, 136: 212-230. 10.1016/j.molbrainres.2005.02.011.PubMed Paris D, Ait-Ghezala G, Mathura VS, Patel N, Quadros A: Anti-angiogenic activity of the mutant Dutch Aβ peptide on human brain microvascular endothelial cells. Mol Brain Res. 2005, 136: 212-230. 10.1016/j.molbrainres.2005.02.011.PubMed
117.
go back to reference Monro OR, Mackic JB, Yamada S, Segal MB, Ghiso J, Maurer C, Calero M, Frangione B, Zlokovic BV: Substitution at codon 22 reduces clearance of Alzheimer's amyloid-beta peptide from the cerebrospinal fluid and prevents its transport from the central nervous system into blood. Neurobiol Aging. 2002, 23: 405-412. 10.1016/S0197-4580(01)00317-7.PubMed Monro OR, Mackic JB, Yamada S, Segal MB, Ghiso J, Maurer C, Calero M, Frangione B, Zlokovic BV: Substitution at codon 22 reduces clearance of Alzheimer's amyloid-beta peptide from the cerebrospinal fluid and prevents its transport from the central nervous system into blood. Neurobiol Aging. 2002, 23: 405-412. 10.1016/S0197-4580(01)00317-7.PubMed
118.
go back to reference Grammas P, Botchlet T, Fugate R, Ball MJ, Roher AE: Alzheimer disease amyloid proteins inhibit brain endothelial cell proliferation in vitro. Dementia. 1995, 6: 126-130.PubMed Grammas P, Botchlet T, Fugate R, Ball MJ, Roher AE: Alzheimer disease amyloid proteins inhibit brain endothelial cell proliferation in vitro. Dementia. 1995, 6: 126-130.PubMed
119.
go back to reference Wu Z, Guo H, Chow N, Sallstrom J, Bell RD, Deane R, Brooks AI, Kanagala S, Rubio A, Sagare A, Liu D, Li F, Armstrong D, Gasiewicz T, Zidovetzki R, Song X, Hofman F, Zlokovic BV: Role of the MEOX2 gene in neurovascular dysfunction in Alzheimer disease. Nat Med. 2005, 11: 959-965.PubMed Wu Z, Guo H, Chow N, Sallstrom J, Bell RD, Deane R, Brooks AI, Kanagala S, Rubio A, Sagare A, Liu D, Li F, Armstrong D, Gasiewicz T, Zidovetzki R, Song X, Hofman F, Zlokovic BV: Role of the MEOX2 gene in neurovascular dysfunction in Alzheimer disease. Nat Med. 2005, 11: 959-965.PubMed
120.
go back to reference Felmeden DC, Blann AD, Lip GYH: Angiogenesis: basic pathophysiology and implications for disease. Eur Heart J. 2003, 24: 585-603. 10.1016/S0195-668X(02)00635-8. Felmeden DC, Blann AD, Lip GYH: Angiogenesis: basic pathophysiology and implications for disease. Eur Heart J. 2003, 24: 585-603. 10.1016/S0195-668X(02)00635-8.
121.
go back to reference Milkiewicz M, Ispanovic E, Doyle JL, Haas TL: Regulators of angiogenesis and strategies for their therapeutic manipulation. Int J Biochem Cell Biol. 2006, 38: 333-357. 10.1016/j.biocel.2005.10.006.PubMed Milkiewicz M, Ispanovic E, Doyle JL, Haas TL: Regulators of angiogenesis and strategies for their therapeutic manipulation. Int J Biochem Cell Biol. 2006, 38: 333-357. 10.1016/j.biocel.2005.10.006.PubMed
122.
go back to reference Breitner JC, Welsh KA, Helms MJ, Gaskell PC, Gau BA, Roses AD, Pericak-Vance MA, Saunders AM: Delayed onset of Alzheimer's disease with nonsteroidal anti-inflammatory and histamine H2 blocking drugs. Neurobiol Aging. 1995, 16: 523-530. 10.1016/0197-4580(95)00049-K.PubMed Breitner JC, Welsh KA, Helms MJ, Gaskell PC, Gau BA, Roses AD, Pericak-Vance MA, Saunders AM: Delayed onset of Alzheimer's disease with nonsteroidal anti-inflammatory and histamine H2 blocking drugs. Neurobiol Aging. 1995, 16: 523-530. 10.1016/0197-4580(95)00049-K.PubMed
123.
go back to reference Forette F, Seux ML, Staessen JA, Thijs L, Birkenhager WH, Babarskiene MR, Babeanu S, Bossini A, Gil-Extremera B, Girerd X, Laks T, Lilov E, Moisseyev V, Tuomilehto J, Vanhanen H, Webster J, Yodfat Y, Fagard R: Prevention of dementia in randomized double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial. Lancet. 1998, 352: 1347-1351. 10.1016/S0140-6736(98)03086-4.PubMed Forette F, Seux ML, Staessen JA, Thijs L, Birkenhager WH, Babarskiene MR, Babeanu S, Bossini A, Gil-Extremera B, Girerd X, Laks T, Lilov E, Moisseyev V, Tuomilehto J, Vanhanen H, Webster J, Yodfat Y, Fagard R: Prevention of dementia in randomized double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial. Lancet. 1998, 352: 1347-1351. 10.1016/S0140-6736(98)03086-4.PubMed
124.
go back to reference Wolozin B, Kellman W, Ruosseau P, Celesia GG, Siegel G: Decreased prevalence of Alzheimer's disease associated with 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors. Arch Neurol. 2000, 57: 1439-1443. 10.1001/archneur.57.10.1439.PubMed Wolozin B, Kellman W, Ruosseau P, Celesia GG, Siegel G: Decreased prevalence of Alzheimer's disease associated with 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors. Arch Neurol. 2000, 57: 1439-1443. 10.1001/archneur.57.10.1439.PubMed
125.
go back to reference Vagnucci AD, Li WW: Alzheimer's disease and angiogenesis. Lancet. 2003, 361: 605-608. 10.1016/S0140-6736(03)12521-4.PubMed Vagnucci AD, Li WW: Alzheimer's disease and angiogenesis. Lancet. 2003, 361: 605-608. 10.1016/S0140-6736(03)12521-4.PubMed
126.
go back to reference Lema MJ: Emerging options with coxib therapy. Cleve Clin J Med. 2002, 69 (Suppl 1): S176-S184. Lema MJ: Emerging options with coxib therapy. Cleve Clin J Med. 2002, 69 (Suppl 1): S176-S184.
127.
go back to reference Martel-Pelletier J, Pelletier JP, Fahmi H: Cyclooxygenase-2 and prostaglandins in articular tissues. Semin Arthritis Rheum. 2003, 33: 155-167. 10.1016/S0049-0172(03)00134-3. 40PubMed Martel-Pelletier J, Pelletier JP, Fahmi H: Cyclooxygenase-2 and prostaglandins in articular tissues. Semin Arthritis Rheum. 2003, 33: 155-167. 10.1016/S0049-0172(03)00134-3. 40PubMed
128.
go back to reference De Filippis D, Cipriano M, Esposito G, Scuderi C, Steardo L, Iuvone T: Are anti-angiogenic drugs useful in neurodegenerative disorders?. CNS & Neurological Disorders - Drug Targets. 2010, 9: 807-812. De Filippis D, Cipriano M, Esposito G, Scuderi C, Steardo L, Iuvone T: Are anti-angiogenic drugs useful in neurodegenerative disorders?. CNS & Neurological Disorders - Drug Targets. 2010, 9: 807-812.
129.
go back to reference Jones MK, Wang H, Peskar BM, Levin E, Itani RM, Sarfeh IJ, Tarnawski SS: Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: insight into mechanisms and implications for cancer growth and ulcer healing. Nat Med. 1999, 5: 1418-1423. 10.1038/70995.PubMed Jones MK, Wang H, Peskar BM, Levin E, Itani RM, Sarfeh IJ, Tarnawski SS: Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: insight into mechanisms and implications for cancer growth and ulcer healing. Nat Med. 1999, 5: 1418-1423. 10.1038/70995.PubMed
130.
go back to reference Tarnawski AS, Jones MK: Inhibition of angiogenesis by NSAIDs: molecular mechanisms and clinical implications. J Mol Med. 2003, 81: 627-636. 10.1007/s00109-003-0479-y.PubMed Tarnawski AS, Jones MK: Inhibition of angiogenesis by NSAIDs: molecular mechanisms and clinical implications. J Mol Med. 2003, 81: 627-636. 10.1007/s00109-003-0479-y.PubMed
131.
go back to reference Boonmasawai S, Akarasereenont P, Techatraisak K, Thaworn A, Chotewuttakorn S, Palo T: Effects of selective COX inhibitors and classical NSAIDs on endothelial cell proliferation and migration induced by human cholangiocarcinoma cell culture. J Med Assoc Thai. 2009, 92: 1508-1515.PubMed Boonmasawai S, Akarasereenont P, Techatraisak K, Thaworn A, Chotewuttakorn S, Palo T: Effects of selective COX inhibitors and classical NSAIDs on endothelial cell proliferation and migration induced by human cholangiocarcinoma cell culture. J Med Assoc Thai. 2009, 92: 1508-1515.PubMed
132.
go back to reference Alkam T, Nitta A, Mizoguchi H, Saito K, Seshima M, Itoh A, Yamada K, Nabeshima T: Restraining tumor necrosis factor-alpha by thalidomide prevents the amyloid beta-induced impairment of recognition and memory in mice. Beh Brain Res. 2008, 189: 100-106. 10.1016/j.bbr.2007.12.014. Alkam T, Nitta A, Mizoguchi H, Saito K, Seshima M, Itoh A, Yamada K, Nabeshima T: Restraining tumor necrosis factor-alpha by thalidomide prevents the amyloid beta-induced impairment of recognition and memory in mice. Beh Brain Res. 2008, 189: 100-106. 10.1016/j.bbr.2007.12.014.
133.
go back to reference Ryu JK, McLarnon JG: Thalidomide inhibition of perturbed vasculature and glial-derived tumor necrosis factor-alpha in an animal model of inflamed Alzheimer's disease brain. Neurobiol Dis. 2008, 29: 254-266. 10.1016/j.nbd.2007.08.019.PubMed Ryu JK, McLarnon JG: Thalidomide inhibition of perturbed vasculature and glial-derived tumor necrosis factor-alpha in an animal model of inflamed Alzheimer's disease brain. Neurobiol Dis. 2008, 29: 254-266. 10.1016/j.nbd.2007.08.019.PubMed
134.
go back to reference Araύjo FA, Rocha MA, Mendes JB, Andrade SP: Atorvastatin inhibits inflammatory angiogenesis in mice through down regulation of VEGF, TNF-alpha and TGF-beta1. Biomed Pharmacother. 2010, 64: 29-34. Araύjo FA, Rocha MA, Mendes JB, Andrade SP: Atorvastatin inhibits inflammatory angiogenesis in mice through down regulation of VEGF, TNF-alpha and TGF-beta1. Biomed Pharmacother. 2010, 64: 29-34.
135.
go back to reference Hata Y, Miura M, Asato R, Kita T, Oba K, Kawahara S, Arita R, Kohno R, Nakao S, Ishibashi T: Antiangiogenic mechanisms of simvastatin in retinal endothelial cells. Graefes Arch Clin Exp Ophthalmol. 2010, 248: 667-673. 10.1007/s00417-009-1282-4.PubMed Hata Y, Miura M, Asato R, Kita T, Oba K, Kawahara S, Arita R, Kohno R, Nakao S, Ishibashi T: Antiangiogenic mechanisms of simvastatin in retinal endothelial cells. Graefes Arch Clin Exp Ophthalmol. 2010, 248: 667-673. 10.1007/s00417-009-1282-4.PubMed
136.
go back to reference Wang Q, Yan J, Chen X, Li J, Yang Y, Weng J, Deng C, Yenari MA: Statins: multiple neuroprotective mechanisms in neurodegenerative diseases. Exp Neurol. 2010. Wang Q, Yan J, Chen X, Li J, Yang Y, Weng J, Deng C, Yenari MA: Statins: multiple neuroprotective mechanisms in neurodegenerative diseases. Exp Neurol. 2010.
137.
go back to reference Gimbrone MA: Vascular endothelium, hemodynamic forces and atherogenesis. Am J Pathol. 1999, 155: 1-5. 10.1016/S0002-9440(10)65090-0.PubMedCentralPubMed Gimbrone MA: Vascular endothelium, hemodynamic forces and atherogenesis. Am J Pathol. 1999, 155: 1-5. 10.1016/S0002-9440(10)65090-0.PubMedCentralPubMed
138.
go back to reference Libby P, Ridker PM, Hansson GK, Leducq Transatlantic Network on Atherothrombosis: Inflammation in atherosclerosis: from pathophysiology to practice. J Am Coll Cardiol. 2009, 54: 2129-2138. 10.1016/j.jacc.2009.09.009.PubMedCentralPubMed Libby P, Ridker PM, Hansson GK, Leducq Transatlantic Network on Atherothrombosis: Inflammation in atherosclerosis: from pathophysiology to practice. J Am Coll Cardiol. 2009, 54: 2129-2138. 10.1016/j.jacc.2009.09.009.PubMedCentralPubMed
139.
go back to reference Gimbrone MA: Endothelial dysfunction, biomechanical forces and the pathobiology of atherosclerosis. Trans Am Clin Climatol Assoc. 2010, 121: 115-127.PubMedCentralPubMed Gimbrone MA: Endothelial dysfunction, biomechanical forces and the pathobiology of atherosclerosis. Trans Am Clin Climatol Assoc. 2010, 121: 115-127.PubMedCentralPubMed
140.
go back to reference Bauersachs J, Widder JD: Endothelial dysfunction in heart failure. Pharm Reports. 2008, 60: 119-126. Bauersachs J, Widder JD: Endothelial dysfunction in heart failure. Pharm Reports. 2008, 60: 119-126.
141.
go back to reference Pober JS, Min W, Bradley JR: Mechanisms of endothelial dysfunction, injury and death. Annu Rev Pathol. 2009, 4: 71-95. 10.1146/annurev.pathol.4.110807.092155.PubMed Pober JS, Min W, Bradley JR: Mechanisms of endothelial dysfunction, injury and death. Annu Rev Pathol. 2009, 4: 71-95. 10.1146/annurev.pathol.4.110807.092155.PubMed
142.
go back to reference Andjelkovic AV, Pachter JS: Central nervous system endothelium in neuroinflammatory, neuroinfectious, and neurodegenerative disease. J Neurosci Res. 1998, 51: 423-430. 10.1002/(SICI)1097-4547(19980215)51:4<423::AID-JNR2>3.0.CO;2-E.PubMed Andjelkovic AV, Pachter JS: Central nervous system endothelium in neuroinflammatory, neuroinfectious, and neurodegenerative disease. J Neurosci Res. 1998, 51: 423-430. 10.1002/(SICI)1097-4547(19980215)51:4<423::AID-JNR2>3.0.CO;2-E.PubMed
143.
go back to reference Faraci FM, Lentz SR: Hyperhomocysteinemia, oxidative stress, and cerebral vascular dysfunction. Stroke. 2004, 35: 345-347. 10.1161/01.STR.0000115161.10646.67.PubMed Faraci FM, Lentz SR: Hyperhomocysteinemia, oxidative stress, and cerebral vascular dysfunction. Stroke. 2004, 35: 345-347. 10.1161/01.STR.0000115161.10646.67.PubMed
144.
go back to reference Isingrini E, Desmidt T, Belzung C, Camus V: Endothelial dysfunction: A potential therapeutic target for geriatric depression and brain amyloid deposition in Alzheimer's disease?. Cur Opin Investig Drugs. 2009, 10: 46-55. Isingrini E, Desmidt T, Belzung C, Camus V: Endothelial dysfunction: A potential therapeutic target for geriatric depression and brain amyloid deposition in Alzheimer's disease?. Cur Opin Investig Drugs. 2009, 10: 46-55.
145.
go back to reference Bomboi F, Castello L, Cosentino F, Giubilei F, Orzi F, Volpe M: Alzheimer's disease and endothelial dysfunction. Neurol Sci. 2010, 31: 1-8. 10.1007/s10072-009-0151-6.PubMed Bomboi F, Castello L, Cosentino F, Giubilei F, Orzi F, Volpe M: Alzheimer's disease and endothelial dysfunction. Neurol Sci. 2010, 31: 1-8. 10.1007/s10072-009-0151-6.PubMed
146.
go back to reference Salmina AB, Inzhutova AI, Malinovskaya NA, Petrova MM: Endothelial dysfunction and repair in Alzheimer-type neurodegeneration: Neuronal and glial control. J Alzheimer Dis. 2010, 22: 17-36. Salmina AB, Inzhutova AI, Malinovskaya NA, Petrova MM: Endothelial dysfunction and repair in Alzheimer-type neurodegeneration: Neuronal and glial control. J Alzheimer Dis. 2010, 22: 17-36.
147.
go back to reference Sumpio BE, Riley JT, Dardik A: Cells in focus: endothelial cell. Int J Biochem Cell Biol. 2002, 34: 1508-1512. 10.1016/S1357-2725(02)00075-4.PubMed Sumpio BE, Riley JT, Dardik A: Cells in focus: endothelial cell. Int J Biochem Cell Biol. 2002, 34: 1508-1512. 10.1016/S1357-2725(02)00075-4.PubMed
148.
go back to reference Moser KV, Stöckl P, Humpel C: Cholinergic neurons degenerate when exposed to conditioned medium of primary rat brain capillary endothelial cells: counteraction by NGF, MK-801 and inflammation. Exp Gerontol. 2006, 41: 609-618. 10.1016/j.exger.2006.03.018.PubMed Moser KV, Stöckl P, Humpel C: Cholinergic neurons degenerate when exposed to conditioned medium of primary rat brain capillary endothelial cells: counteraction by NGF, MK-801 and inflammation. Exp Gerontol. 2006, 41: 609-618. 10.1016/j.exger.2006.03.018.PubMed
149.
go back to reference Grammas P, Ottman T, Reimann-Phillip U, Larabee J, Weigel PH: Injured endothelial cells release neurotoxic thrombin. J Alzheimer Dis. 2004, 6: 275-281. Grammas P, Ottman T, Reimann-Phillip U, Larabee J, Weigel PH: Injured endothelial cells release neurotoxic thrombin. J Alzheimer Dis. 2004, 6: 275-281.
150.
go back to reference Bell RD, Winkler EA, Sagare AP, Singh I, LaRue B, Deane R, Zlokovic BV: Pericytes control key neurovascular functions and neuronal phenotype in the adult brain and during aging. Neuron. 2010, 68: 321-323. 10.1016/j.neuron.2010.09.043. Bell RD, Winkler EA, Sagare AP, Singh I, LaRue B, Deane R, Zlokovic BV: Pericytes control key neurovascular functions and neuronal phenotype in the adult brain and during aging. Neuron. 2010, 68: 321-323. 10.1016/j.neuron.2010.09.043.
151.
go back to reference Akiyama H, Ikeda K, Kondo H, McGeer PL: Thrombin accumulation in patients with Alzheimer's disease. Neurosci Lett. 1992, 146: 152-154. 10.1016/0304-3940(92)90065-F.PubMed Akiyama H, Ikeda K, Kondo H, McGeer PL: Thrombin accumulation in patients with Alzheimer's disease. Neurosci Lett. 1992, 146: 152-154. 10.1016/0304-3940(92)90065-F.PubMed
152.
go back to reference Mortimer JA, van Duijn CM, Chandra V, Fratiglioni L, Graves AB, Heyman A: Head trauma as a risk factor for Alzheimer's disease: a collaborative re-analysis of case-control studies. EURODEM Risk Factors Research Group. Int J Epidemiol. 1991, 20: S28-S35.PubMed Mortimer JA, van Duijn CM, Chandra V, Fratiglioni L, Graves AB, Heyman A: Head trauma as a risk factor for Alzheimer's disease: a collaborative re-analysis of case-control studies. EURODEM Risk Factors Research Group. Int J Epidemiol. 1991, 20: S28-S35.PubMed
153.
go back to reference Nemetz PN, Leibson C, Naessens JM, Beard M, Kokmen E, Annegers JF, Kurland LT: Traumatic brain injury and time to onset of Alzheimer's disease: a population based study. Am J Epidemiol. 1999, 149: 32-40.PubMed Nemetz PN, Leibson C, Naessens JM, Beard M, Kokmen E, Annegers JF, Kurland LT: Traumatic brain injury and time to onset of Alzheimer's disease: a population based study. Am J Epidemiol. 1999, 149: 32-40.PubMed
154.
go back to reference Nishino A, Suzuki M, Ohtani H, Motohashi O, Umezawa K, Nagura H, Yoshimoto T: Thrombin may contribute to the pathophysiology of central nervous system injury. J Neurotraum. 1993, 10: 167-179. 10.1089/neu.1993.10.167. Nishino A, Suzuki M, Ohtani H, Motohashi O, Umezawa K, Nagura H, Yoshimoto T: Thrombin may contribute to the pathophysiology of central nervous system injury. J Neurotraum. 1993, 10: 167-179. 10.1089/neu.1993.10.167.
155.
go back to reference Sokolova e, Reiser G: Prothrombin/thrombin and the thrombin receptors PAR-1 and PAR-4 in the brain: localization, expression and participation in neurodegenerative diseases. Thromb Haemost. 2008, 100: 576-581.PubMed Sokolova e, Reiser G: Prothrombin/thrombin and the thrombin receptors PAR-1 and PAR-4 in the brain: localization, expression and participation in neurodegenerative diseases. Thromb Haemost. 2008, 100: 576-581.PubMed
156.
go back to reference Vaughan PL, Su J, Cotman CW, Cunningham D: Protease nexin-1, a potent thrombin inhibitor, is reduced around cerebral blood vessels in Alzheimer's disease. Neuroreport. 1994, 5: 2529-2533. 10.1097/00001756-199412000-00031. Vaughan PL, Su J, Cotman CW, Cunningham D: Protease nexin-1, a potent thrombin inhibitor, is reduced around cerebral blood vessels in Alzheimer's disease. Neuroreport. 1994, 5: 2529-2533. 10.1097/00001756-199412000-00031.
157.
go back to reference Maragoudakis ME, Tsopanoglou NE, Andriopoulou P: Mechanism of thrombin-induced angiogenesis. Biochem Soc Trans. 2002, 30: 173-177. 10.1042/BST0300173.PubMed Maragoudakis ME, Tsopanoglou NE, Andriopoulou P: Mechanism of thrombin-induced angiogenesis. Biochem Soc Trans. 2002, 30: 173-177. 10.1042/BST0300173.PubMed
158.
go back to reference Naldini A, Carney DH, Pucci A, Pasquali A, Carraro F: Thrombin regulates the expression of proangiogenic cytokines via proteolytic activation of protease-activated receptor-1. Gen Pharmacol. 2000, 35: 255-259.PubMed Naldini A, Carney DH, Pucci A, Pasquali A, Carraro F: Thrombin regulates the expression of proangiogenic cytokines via proteolytic activation of protease-activated receptor-1. Gen Pharmacol. 2000, 35: 255-259.PubMed
159.
go back to reference Dupuy E, Habib A, Lebret M, Yang R, Levy-Toledano S, Tobelem G: Thrombin induces angiogenesis and vascular endothelial growth factor expression in human endothelial cells: possible relevance to HIF-1α. J Thromb Haemost. 2003, 1: 1096-1102. 10.1046/j.1538-7836.2003.00208.x.PubMed Dupuy E, Habib A, Lebret M, Yang R, Levy-Toledano S, Tobelem G: Thrombin induces angiogenesis and vascular endothelial growth factor expression in human endothelial cells: possible relevance to HIF-1α. J Thromb Haemost. 2003, 1: 1096-1102. 10.1046/j.1538-7836.2003.00208.x.PubMed
160.
go back to reference Tsopanoglou NE, Andriopoulou P, Maragoudakis ME: On the mechanism of thrombin-induced angiogenesis: involvement of alphavbeta3-integrin. Am J Physiol. 2002, 283: C1501-C1510. Tsopanoglou NE, Andriopoulou P, Maragoudakis ME: On the mechanism of thrombin-induced angiogenesis: involvement of alphavbeta3-integrin. Am J Physiol. 2002, 283: C1501-C1510.
161.
go back to reference Smirnova , Zhang SX, Citron BA, Arnold PM, Festoff BW: Thrombin is an extracellular signal that activates intracellular death protease pathways inducing apoptosis in model motor neurons. J Neurobiol. 1998, 36: 64-80. 10.1002/(SICI)1097-4695(199807)36:1<64::AID-NEU6>3.0.CO;2-8.PubMed Smirnova , Zhang SX, Citron BA, Arnold PM, Festoff BW: Thrombin is an extracellular signal that activates intracellular death protease pathways inducing apoptosis in model motor neurons. J Neurobiol. 1998, 36: 64-80. 10.1002/(SICI)1097-4695(199807)36:1<64::AID-NEU6>3.0.CO;2-8.PubMed
162.
go back to reference Turgeon VL, Milligan CE, Houenou LJ: Activation of the protease-activated thrombin receptor (PAR)-1 induces motoneuron degeneration in the developing avian embryo. J Neuropathol Exp. 1999, 58: 499-504. 10.1097/00005072-199905000-00009. Turgeon VL, Milligan CE, Houenou LJ: Activation of the protease-activated thrombin receptor (PAR)-1 induces motoneuron degeneration in the developing avian embryo. J Neuropathol Exp. 1999, 58: 499-504. 10.1097/00005072-199905000-00009.
163.
go back to reference Festoff BW, D'Andrea MR, Citron BA, Salcedo RM, Smirnova IV, Andrade-Gordon P: Motor neuron cell death in wobbler mutant mice follows overexpression of the G-protein coupled, protease-activated receptor for thrombin. Mol Med. 2000, 6: 410-429.PubMedCentralPubMed Festoff BW, D'Andrea MR, Citron BA, Salcedo RM, Smirnova IV, Andrade-Gordon P: Motor neuron cell death in wobbler mutant mice follows overexpression of the G-protein coupled, protease-activated receptor for thrombin. Mol Med. 2000, 6: 410-429.PubMedCentralPubMed
164.
go back to reference Reimann-Philipp U, Ovase R, Lapus M, Weigel PH, Grammas P: Mechanisms of cell death in primary cortical neurons and PC12 cells. J Neurosci Res. 2001, 64: 654-660. 10.1002/jnr.1119.PubMed Reimann-Philipp U, Ovase R, Lapus M, Weigel PH, Grammas P: Mechanisms of cell death in primary cortical neurons and PC12 cells. J Neurosci Res. 2001, 64: 654-660. 10.1002/jnr.1119.PubMed
165.
go back to reference Suo Z, Wu M, Citron BA, Palazzo RE, Festoff BW: Rapid tau aggregation and delayed hippocampal neuronal death induced by persistent thrombin signaling. J Biol Chem. 2003, 278: 37681-37689. 10.1074/jbc.M301406200.PubMed Suo Z, Wu M, Citron BA, Palazzo RE, Festoff BW: Rapid tau aggregation and delayed hippocampal neuronal death induced by persistent thrombin signaling. J Biol Chem. 2003, 278: 37681-37689. 10.1074/jbc.M301406200.PubMed
166.
go back to reference Mhatre M, Nguyen A, Pham T, Adesina A, Grammas P: Thrombin, a mediator of neurotoxicity and memory impairment. Neurobiol Aging. 2004, 25: 783-79. 10.1016/j.neurobiolaging.2003.07.007.PubMed Mhatre M, Nguyen A, Pham T, Adesina A, Grammas P: Thrombin, a mediator of neurotoxicity and memory impairment. Neurobiol Aging. 2004, 25: 783-79. 10.1016/j.neurobiolaging.2003.07.007.PubMed
167.
go back to reference Lee da Y, Park KW, Jin BK: Thrombin induces neurodegeneration and microglial activation in the cortex in vivo and in vitro: proteolytic and non-proteolytic actions. Biochem Biophys Res Commun. 2006, 346: 727-738. 10.1016/j.bbrc.2006.05.174.PubMed Lee da Y, Park KW, Jin BK: Thrombin induces neurodegeneration and microglial activation in the cortex in vivo and in vitro: proteolytic and non-proteolytic actions. Biochem Biophys Res Commun. 2006, 346: 727-738. 10.1016/j.bbrc.2006.05.174.PubMed
168.
go back to reference Luo W, Wang Y, Reiser G: Protease-activated receptors in the brain: receptor expression, activation, and functions in neurodegeneration. Brain Res Rev. 2007, 56: 331-345. 10.1016/j.brainresrev.2007.08.002.PubMed Luo W, Wang Y, Reiser G: Protease-activated receptors in the brain: receptor expression, activation, and functions in neurodegeneration. Brain Res Rev. 2007, 56: 331-345. 10.1016/j.brainresrev.2007.08.002.PubMed
169.
go back to reference Park KW, Jin BK: Thrombin-induced oxidative stress contributes to the death of hippocampal neurons: role of neuronal NADPH oxidase. J Neurosci Res. 2008, 86: 1053-1063. 10.1002/jnr.21571.PubMed Park KW, Jin BK: Thrombin-induced oxidative stress contributes to the death of hippocampal neurons: role of neuronal NADPH oxidase. J Neurosci Res. 2008, 86: 1053-1063. 10.1002/jnr.21571.PubMed
170.
go back to reference Rao HV, Thirumangalakudi L, Grammas P: Cyclin C and cyclin dependent kinases 1,2 and 3 in thrombin-induced neuronal cell cycle progression and apoptosis. Neurosci Lett. 2009, 450: 347-350. 10.1016/j.neulet.2008.12.018.PubMedCentralPubMed Rao HV, Thirumangalakudi L, Grammas P: Cyclin C and cyclin dependent kinases 1,2 and 3 in thrombin-induced neuronal cell cycle progression and apoptosis. Neurosci Lett. 2009, 450: 347-350. 10.1016/j.neulet.2008.12.018.PubMedCentralPubMed
171.
go back to reference Huang CF, Li G, Ma R, Sun SG, Chen JG: Thrombin-induced microglial activation contributes to the degeneration of nigral dopaminergic neurons in vivo. Neurosci Bull. 2008, 24: 66-72. 10.1007/s12264-008-0066-x.PubMed Huang CF, Li G, Ma R, Sun SG, Chen JG: Thrombin-induced microglial activation contributes to the degeneration of nigral dopaminergic neurons in vivo. Neurosci Bull. 2008, 24: 66-72. 10.1007/s12264-008-0066-x.PubMed
172.
go back to reference Huang C, Ma R, Sun S, Wei G, Fang Y, Liu R, Li G: JAK2-STAT3 signaling pathway mediates thrombin-induced proinflammatory actions of microglia in vitro. J Neuroimmunol. 2008, 204: 118-125. 10.1016/j.jneuroim.2008.07.004.PubMed Huang C, Ma R, Sun S, Wei G, Fang Y, Liu R, Li G: JAK2-STAT3 signaling pathway mediates thrombin-induced proinflammatory actions of microglia in vitro. J Neuroimmunol. 2008, 204: 118-125. 10.1016/j.jneuroim.2008.07.004.PubMed
173.
go back to reference Choi MS, Kim YE, Lee WJ, Choi JW, Park GH, Kim SD, Jeon SJ, Go HS, Shin SM, Kim WK, Shin Cy, Ko KH: Activation of protease-activated receptor1 mediates induction of matrix metalloproteinase-9 by thrombin in rat primary astrocytes. Brain Res Bull. 2008, 76: 368-375. 10.1016/j.brainresbull.2008.02.031.PubMed Choi MS, Kim YE, Lee WJ, Choi JW, Park GH, Kim SD, Jeon SJ, Go HS, Shin SM, Kim WK, Shin Cy, Ko KH: Activation of protease-activated receptor1 mediates induction of matrix metalloproteinase-9 by thrombin in rat primary astrocytes. Brain Res Bull. 2008, 76: 368-375. 10.1016/j.brainresbull.2008.02.031.PubMed
174.
go back to reference Park JA, Choi KS, Kim SY, Kim KW: Coordinated interaction of the vascular and nervous systems: from molecule- to cell-based approaches. Biochem Biophys Res Commun. 2003, 311: 247-253. 10.1016/j.bbrc.2003.09.129.PubMed Park JA, Choi KS, Kim SY, Kim KW: Coordinated interaction of the vascular and nervous systems: from molecule- to cell-based approaches. Biochem Biophys Res Commun. 2003, 311: 247-253. 10.1016/j.bbrc.2003.09.129.PubMed
175.
go back to reference Benarroch E: Neurovascular unit dysfunction: A vascular component of Alzheimer's disease?. Neurology. 2007, 68: 1730-1732. 10.1212/01.wnl.0000264502.92649.ab.PubMed Benarroch E: Neurovascular unit dysfunction: A vascular component of Alzheimer's disease?. Neurology. 2007, 68: 1730-1732. 10.1212/01.wnl.0000264502.92649.ab.PubMed
176.
go back to reference Lok J, Gupta P, Guo S, Kim WJ, Whalen MJ, van Leyen K, Lo EH: Cell-cell signaling in the neurovascular unit. Neurochem Res. 2007, 32: 2032-2045. 10.1007/s11064-007-9342-9.PubMed Lok J, Gupta P, Guo S, Kim WJ, Whalen MJ, van Leyen K, Lo EH: Cell-cell signaling in the neurovascular unit. Neurochem Res. 2007, 32: 2032-2045. 10.1007/s11064-007-9342-9.PubMed
177.
go back to reference Guo S, Lo EH: Dysfunctional cell-cell signaling in the neurovascular unit as a paradigm for central nervous system disease. Stroke. 2009, 40 (suppl 1): S4-S7. 10.1161/STROKEAHA.108.534388.PubMedCentralPubMed Guo S, Lo EH: Dysfunctional cell-cell signaling in the neurovascular unit as a paradigm for central nervous system disease. Stroke. 2009, 40 (suppl 1): S4-S7. 10.1161/STROKEAHA.108.534388.PubMedCentralPubMed
178.
go back to reference Zacchigna S, Lambrechts D, Carmeliet P: Neurovascular signaling defects in neurodegeneration. Nat Rev Neurosci. 2008, 9: 169-181. 10.1038/nrn2336.PubMed Zacchigna S, Lambrechts D, Carmeliet P: Neurovascular signaling defects in neurodegeneration. Nat Rev Neurosci. 2008, 9: 169-181. 10.1038/nrn2336.PubMed
179.
go back to reference Zeevi N, Pachter J, McCullough LD, Wolfson L, Kuchel GA: The blood-brain barrier: geriatric relevance of a critical brain-body interface. J Am Geriatr Soc. 2010, 58: 1749-1757. 10.1111/j.1532-5415.2010.03011.x.PubMedCentralPubMed Zeevi N, Pachter J, McCullough LD, Wolfson L, Kuchel GA: The blood-brain barrier: geriatric relevance of a critical brain-body interface. J Am Geriatr Soc. 2010, 58: 1749-1757. 10.1111/j.1532-5415.2010.03011.x.PubMedCentralPubMed
180.
go back to reference Deane R, Wu Z, Zlokovic BV: RAGE (yin) versus LRP (yang) balance regulates Alzheimer amyloid beta-peptide clearance through transport across the blood-brain barrier. Stroke. 2004, 35: 2628-2631. 10.1161/01.STR.0000143452.85382.d1.PubMed Deane R, Wu Z, Zlokovic BV: RAGE (yin) versus LRP (yang) balance regulates Alzheimer amyloid beta-peptide clearance through transport across the blood-brain barrier. Stroke. 2004, 35: 2628-2631. 10.1161/01.STR.0000143452.85382.d1.PubMed
181.
go back to reference Bell RD, Zlokovic BV: Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease. Acta Neuropathol. 2009, 118: 103-113. 10.1007/s00401-009-0522-3.PubMedCentralPubMed Bell RD, Zlokovic BV: Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease. Acta Neuropathol. 2009, 118: 103-113. 10.1007/s00401-009-0522-3.PubMedCentralPubMed
182.
go back to reference Bartha K, Dömötör E, Lanza F, Adam-Vizi V, Machovick R: Identification of thrombin receptors in rat brain capillary endothelial cells. J Cereb Blood Flow. 2000, 20: 175-182. 10.1097/00004647-200001000-00022. Bartha K, Dömötör E, Lanza F, Adam-Vizi V, Machovick R: Identification of thrombin receptors in rat brain capillary endothelial cells. J Cereb Blood Flow. 2000, 20: 175-182. 10.1097/00004647-200001000-00022.
183.
go back to reference Igarashi K, Murai H, Asaka J: Proteolytic processing of amyloid beta protein precursor (APP) by thrombin. Biochem Biophys Res. 1992, 185: 1000-1004. 10.1016/0006-291X(92)91726-7. Igarashi K, Murai H, Asaka J: Proteolytic processing of amyloid beta protein precursor (APP) by thrombin. Biochem Biophys Res. 1992, 185: 1000-1004. 10.1016/0006-291X(92)91726-7.
184.
go back to reference Ciallela JR, Figueiredo H, Smith-Swintosky V, McGillis JP: Thrombin induces surface and intracellular secretion of amyloid precursor protein from human endothelial cells. Thromb Haemost. 1999, 81: 630-637. Ciallela JR, Figueiredo H, Smith-Swintosky V, McGillis JP: Thrombin induces surface and intracellular secretion of amyloid precursor protein from human endothelial cells. Thromb Haemost. 1999, 81: 630-637.
Metadata
Title
Neurovascular dysfunction, inflammation and endothelial activation: Implications for the pathogenesis of Alzheimer's disease
Author
Paula Grammas
Publication date
01-12-2011
Publisher
BioMed Central
Published in
Journal of Neuroinflammation / Issue 1/2011
Electronic ISSN: 1742-2094
DOI
https://doi.org/10.1186/1742-2094-8-26

Other articles of this Issue 1/2011

Journal of Neuroinflammation 1/2011 Go to the issue